Trident Lifeline Limited has successfully completed the acquisition of 51% stake in Trident Mediquip Limited (TML), as of February 4, 2025, at 09:32 AM. This acquisition involves the acquisition of a significant shareholding in TML, a company incorporated under CIN: U33309GJ2019PLC110421, and makes T-Med Biovation Private Limited (a wholly-owned subsidiary of TML) a stepdown subsidiary of Trident Lifeline Limited.

Transaction Details:

• Acquiring Company: Trident Lifeline Limited (TLL)
• Target Entity: Trident Mediquip Limited (TML)
• Target Subsidiary: T-Med Biovation Private Limited
• Completion Date: February 4, 2025
• Percentage of Stake Acquired: 51% in TML, making T-Med a stepdown subsidiary.
• Post-Acquisition Holding: T-Med Biovation becomes a wholly-owned subsidiary of TML, which is a subsidiary of TLL.

Acquisition Impact:

The strategic acquisition will allow Trident Lifeline to tap into the fast-growing pharmaceuticals and medical & surgical equipment markets. T-Med Biovation, which was incorporated in July 2020, is focused on pharmaceutical products. Although the company had a modest turnover over the past years, with Rs. 32,007 in the 2023-24 financial year, the acquisition is seen as a long-term investment in the healthcare sector.

Related Party Transaction:

The acquisition involves a related party transaction, as T-Med Biovation is a wholly-owned subsidiary of Trident Mediquip. The company’s promoters and board members also have interests in T-Med. Despite the related party status, the transaction is at arm’s length.

No Regulatory Approvals Required:

There were no additional regulatory approvals required for this acquisition, which is now officially completed.

For updates on this strategic acquisition and more business growth strategies, stay tuned to the latest corporate news.

The Upcoming IPOs in this week and coming weeks are Ken Enterprises, Amwill Healthcare, Readymix Construction, Solarium Green, Eleganz Interiors.

The Current active IPO is Chamunda Electricals.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Join our Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.